Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine and standardized behavior therapy in adult ADHD
2006-004073-10Phase 3Completed
- Sponsor
- Justus Liebig University Giessen
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Justus Liebig University Giessen. Primary endpoint: Completion of full protocol at 18 weeks. Started Aug 2006; status: completed.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2006-004073-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004073-10.